Tert-butyl 4-(2-(methoxycarbonyl)phenyl)piperazine-1-carboxylate, 98%, 500mg

Tirabrutinib, 99.65%, 50mg

3-(5-bromo-2-fluorophenyl)-5-methyl-4,5-dihydro-1,2-oxazole-5-carboxylic acid, 95.0%, 2g

ETHYL 2-BROMO-5-(TRIFLUOROMETHYL)-1H-IMIDAZOLE-4-CARBOXYLATE, 95.0%, 100mg

Glycosynthase (Endo-M-N175Q) Recombinant: from Mucor hiemalis expressed in Escherichia coli (100m units/vial)1vial

1-(4-Aminophenyl)pyrrolidine-2,5-dione, 1g

7-Bromo-4,6-dichloro-8-fluoro-3-nitroquinoline, 98%, 25mg

Metanolo D4 con TMS (0,03 vol%), 99,8 at%D, 7,5 ml, confezione in vetroamp.

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)piperazine hydrochloride, 97%, 10g

1-Phenyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 100mg

5-(trifluoromethyl)-1H-pyrazol-4-amine, 98+%, 500mg

1-O-TOLYLPYRAZOLE, 97.0%, 1g

(R)-2-Methyltetrahydrofuran-2-carboxylic acid, 98%, 500mg